Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Jan 27, 2021; 13(1): 50-75
Published online Jan 27, 2021. doi: 10.4240/wjgs.v13.i1.50
Published online Jan 27, 2021. doi: 10.4240/wjgs.v13.i1.50
Recurrence, n = 234 | Timing of recurrence, n = 60 | ||||||||
All | No | Yes | HR | P value | Early recurrence (< 3 yr) | Late recurrence (≥ 3 yr) | OR | P value | |
n, % | n = 174 (67.7%) | n = 60 (23.3%) | n = 51 (85.0%) | n = 9 (15.0%) | |||||
Neoadjuvant therapy, n (%) | 0.921 | 0.949 | |||||||
No | 97 (93.3) | 68 (70) | 29 (30) | Reference | 25 (86.2) | 4 (13.8) | Reference | ||
Yes | 7 (6.7) | 5 (71) | 2 (29) | 1.07 (0.26-4.51) | 2 (100) | 0 (0) | 1.13 (0.02-53.57) | ||
Missing | 130 | 130 | 29 | ||||||
Surgery, n (%) | |||||||||
Right emicolectomy | 55 (23.5) | 42 (76.4) | 13 (23.6) | Reference | 10 (76.9) | 3 (23.1) | Reference | ||
Extended right emicolectomy | 15 (6.4) | 12 (80) | 3 (20) | 1.16 (0.37-3.59) | 0.801 | 2 (66.7) | 1 (33.3) | 4.20 (0.37-47.64) | 0.247 |
Intermediate colectomy | 10 (4.3) | 6 (60) | 4 (40) | 2.16 (0.70-6.71) | 0.182 | 3 (75) | 1 (25) | 1.80 (0.14-23.6) | 0.655 |
AR/Hartmann | 106 (45.3) | 80 (75.5) | 26 (24.5) | 1.09 (0.55-2.17) | 0.798 | 24 (92.3) | 2 (7.7) | 0.43 (0.06-3.02) | 0.395 |
LAR/Miles | 38 (16.2) | 28 (73.7) | 10 (26.3) | 1.16 (0.50-2.68) | 0.731 | 8 (80) | 2 (20) | 1.23 (0.16-9.69) | 0.841 |
Total/Sub-total Colectomy | 6 (2.6) | 3 (50) | 3 (50) | 2.69 (0.76-9.53) | 0.126 | 3 (100) | 0 (0.0) | 0.60 (0.01-24.50) | 0.787 |
Segmental resection | 4 (1.7) | 3 (75) | 1 (25) | 1.12 (0.14-8.68) | 0.916 | 1 (100) | 0 (0.0) | 1.7 (0.02-162.35) | 0.819 |
Associated procedure, n (%) | |||||||||
No | 52 (50.5) | 39 (75) | 13 (25) | Reference | 11 (84.6) | 2 (15.4) | Reference | ||
Minor | 40 (38.8) | 27 (67.5) | 13 (32.5) | 1.30 (0.60-2.80) | 0.505 | 11 (84.6) | 2 (15.4) | 1.00 (0.13-7.44) | 1.00 |
Major | 11 (10.7) | 4 (36.4) | 7 (63.6) | 3.56 (1.41-8.96) | 0.007 | 7 (100) | 0 (0) | 0.31 (0.01-8.95) | 0.492 |
Missing | 131 | 131 | 27 | ||||||
Operative technique, n (%) | < 0.001 | 0.061 | |||||||
Open | 99 (42.7) | 61 (61.6) | 38 (38.4) | Reference | 35 (92.1) | 3 (7.9) | Reference | ||
Laparoscopy | 133 (57.3) | 111 (83.5) | 22 (16.5) | 0.37 (0.22-0.62) | 16 (72.7) | 6 (27.3) | 4.00 (0.94-17.01) | ||
Missing | 2 | 2 | - | ||||||
Duration of surgery, min – mean ± SD | 232 ± 67 | 230 ± 61 | 239 ± 83 | 1.00 (0.99-1.01) | 0.496 | 238 ± 78 | 242 ± 112 | 1.00 (0.99-1.01) | 0.808 |
Postop blood transfusion, n (%) | 0.123 | 0.119 | |||||||
No | 174 (75.7) | 134 (77) | 40 (23) | Reference | 36 (90) | 4 (10) | Reference | ||
Yes | 56 (24.3) | 37 (66.1) | 19 (33.9) | 1.54 (0.89-2.66) | 14 (73.7) | 5 (26.3) | 3.08 (0.75-12.64) | ||
Missing | 4 | 4 | 1 | ||||||
Reoperation, n (%) | 0.262 | 0.559 | |||||||
No | 82 (91.1) | 60 (73.2) | 22 (26.8) | Reference | 17 (77.3) | 5 (22.7) | Reference | ||
Yes | 8 (8.9) | 5 (62.5) | 3 (37.5) | 1.99 (0.60-6.61) | 2 (66.7) | 1 (33.3) | 2.13 (0.17-26.68) | ||
Missing | 144 | 144 | 35 | ||||||
Hospital stay, d, mean ± SD | 9.2 ± 6 | 8.7 ± 3.7 | 10.9 ± 9.1 | 1.05 (1.02-1.07) | 0.001 | 10.9 ± 9.8 | 10.6 ± 4.0 | 1.01 (0.95-1.08) | 0.737 |
Adjuvant therapy, n (%) | 0.064 | 0.057 | |||||||
No | 127 (56.4) | 103 (81.1) | 24 (18.9) | Reference | 18 (75) | 6 (25) | Reference | ||
Yes | 98 (43.5) | 67 (68.4) | 31 (31.6) | 1.65 (0.97-2.81) | 28 (90.3) | 3 (9.7) | 0.22 (0.04-1.04) | ||
Missing | 9 | 9 | 5 | ||||||
Start of adj CHT, n (%) | 0.268 | 0.401 | |||||||
< 6 wk | 26 (48.1) | 13 (50) | 13 (50) | Reference | 12 (92.3) | 1 (7.7) | Reference | ||
≥ 6 wk | 28 (51.9) | 19 (67.9) | 9 (32.1) | 1.63 (0.69-3.95) | 8 (88.9) | 1 (11.1) | 4.4 (0.14-141.01) | ||
Missing | 180 | 180 | 38 |
- Citation: Melli F, Bartolini I, Risaliti M, Tucci R, Ringressi MN, Muiesan P, Taddei A, Amedei A. Evaluation of prognostic factors and clinicopathological patterns of recurrence after curative surgery for colorectal cancer. World J Gastrointest Surg 2021; 13(1): 50-75
- URL: https://www.wjgnet.com/1948-9366/full/v13/i1/50.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i1.50